<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">phkinetica</journal-id><journal-title-group><journal-title xml:lang="ru">Фармакокинетика и Фармакодинамика</journal-title><trans-title-group xml:lang="en"><trans-title>Pharmacokinetics and Pharmacodynamics</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2587-7836</issn><issn pub-type="epub">2686-8830</issn><publisher><publisher-name>ООО «Издательство ОКИ»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.37489/2587-7836-2020-2-22-27</article-id><article-id custom-type="elpub" pub-id-type="custom">phkinetica-245</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ДОКЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯ ФАРМАКОКИНЕТИКИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>PRECLINICAL PHARMACOKINETIC STUDIES</subject></subj-group></article-categories><title-group><article-title>Экспериментальное изучение системной биодоступности препарата «Гармина гидрохлорид, капсулы» в сравнении с нативным гармином на кроликах породы Шиншилла</article-title><trans-title-group xml:lang="en"><trans-title>An experimental study of the systemic bioavailability of the drug "Harmin hydrochloride, capsules" in comparison with native garmin on chinchilla rabbits</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7588-6174</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Адекенов</surname><given-names>С. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Adekenov</surname><given-names>S. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Адекенов Сергазы Мынжасарови – д. х. н., профессор, академик Национальной академии наук Республики Казахстан, генеральный директор</p><p>Караганда</p></bio><bio xml:lang="en"><p>Adekenov Sergazy M. – D. Sci. in Chemical, professor, Academician of the National Academy of Sciences of the Republic of Kazakhstan, General Director</p><p>Karaganda</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шнаукшта</surname><given-names>В. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Schnaukshta</surname><given-names>V. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Шнаукшта Валентина Станиславовна – к. б. н., доцент, заведующий лабораторией фармакологических испытаний (ЛФИ) ТФ</p><p>Нур-Султан</p></bio><bio xml:lang="en"><p>Schnaukshta Valentina S. – Candidate of Biological Sciences, Associate Professor, Head of the Laboratory of Pharmacological Testing (LFI)</p><p>Nur-Sultan</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4195-7901</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Епифанцева</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Epifantseva</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Епифанцева Елена Валериевна – PhD-докторант. SPIN-код: 5243-3894</p><p>Нур-Султан</p></bio><bio xml:lang="en"><p>Epifantseva Elena V. – PhD doctoral student. SPIN code: 5243-3894</p><p>Nur-Sultan</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6888-3223</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Абаимов</surname><given-names>Д. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Abaimov</surname><given-names>D. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Абаимов Денис Александрович – к. б. н., с. н. с. лаборатории гемореологии, гемостаза и фармакокинетики с клинической и лабораторной диагностикой. SPIN-код: 7548-0933</p><p>Москва</p></bio><bio xml:lang="en"><p>Abaimov Denis A. – Candidate of Biological Sciences, Senior Researcher at the Laboratory of Hemorheology, Hemostasis and Pharmacokinetics with Clinical and Laboratory Diagnostics. SPIN code: 7548-0933</p><p>Moscow</p></bio><email xlink:type="simple">abaidenis@yandex.ru</email><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2804-7770</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Абдрахманова</surname><given-names>М. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Abdrakhmanova</surname><given-names>M. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Абдрахманова Майра Галимжановна – д. м. н., профессор, кафедры неврологии</p><p>Нур-Султан</p></bio><bio xml:lang="en"><p>Abdrakhmanova Mayra G. – D. Sci. in Medicine, professor, Department of Neurology</p><p>Nur-Sultan</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1603-067X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сариев</surname><given-names>А. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Sariev</surname><given-names>A. K.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Сариев Абрек Куангалиевич – д. м. н., профессор, кафедры неврологии. SPIN-код: 3945-1271</p><p>Москва</p></bio><bio xml:lang="en"><p>Sariev Abrek K. – D. Sci. in Medicine, professor, Department of Neurology. SPIN code: 3945-1271</p><p>Moscow</p></bio><xref ref-type="aff" rid="aff-5"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>АО «Международный научно-производственный холдинг «Фитохимия»</institution><country>Казахстан</country></aff><aff xml:lang="en"><institution>JSC "International Research and Production Holding "Phytochemistry"</institution><country>Kazakhstan</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>РГП на ПХВ «Национальный центр экспертизы лекарственных средств и медицинских изделий» Комитета контроля качества и безопасности товаров и услуг Министерства здравоохранения Республики Казахстан</institution><country>Казахстан</country></aff><aff xml:lang="en"><institution>Republican State Enterprise on the Right of Economic Management "National Center for Expertise of Medicines and Medical Devices" of the Ministry of Health of the RK</institution><country>Kazakhstan</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>НАО «Медицинский университет Астаны» МЗ РК</institution><country>Казахстан</country></aff><aff xml:lang="en"><institution>"Астана Medical University" Non-commercial joint-stock company</institution><country>Kazakhstan</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>ФГБНУ «Научный центр неврологии»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Research Center of Neurology</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-5"><aff xml:lang="ru"><institution>ФГАОУ ВО Первый Московский Государственный Медицинский Университет им И.М. Сеченова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>FSAEI HE I.M. Sechenov First MSMU MOH Russia (Sechenovskiy University)</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>01</day><month>12</month><year>2020</year></pub-date><volume>0</volume><issue>2</issue><fpage>22</fpage><lpage>27</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Адекенов С.М., Шнаукшта В.С., Епифанцева Е.В., Абаимов Д.А., Абдрахманова М.Г., Сариев А.К., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Адекенов С.М., Шнаукшта В.С., Епифанцева Е.В., Абаимов Д.А., Абдрахманова М.Г., Сариев А.К.</copyright-holder><copyright-holder xml:lang="en">Adekenov S.M., Schnaukshta V.S., Epifantseva E.V., Abaimov D.A., Abdrakhmanova M.G., Sariev A.K.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.pharmacokinetica.ru/jour/article/view/245">https://www.pharmacokinetica.ru/jour/article/view/245</self-uri><abstract><p>В эксперименте на 12 кроликах-самцах породы Шиншилла проведено сравнительное исследование относительной биодоступности природного алкалоида гармина (нативного, в виде основания) и его производного гармина гидрохлорида, которые вводились перорально, в дозе 50 мг, в виде двух капсул, содержащих эквимолярное количество гармина (25 мг). Показано, что гармина гидрохлорид в сравнении с нативным гармином обладает фармакокинетическими преимуществами в виде сравнительно быстрого достижения максимальной концентрации (Tmax) в плазме крови и достоверно большего значения максимальной концентрации действующего вещества в крови. В то же время показано, что химическая модификация гармина не оказывает значимого влияния на такой параметр, как площадь под фармакокинетической кривой, что свидетельствует об отсутствии разницы в степени абсорбции у сравниваемых лекарственных форм.</p></abstract><trans-abstract xml:lang="en"><p>An experimental comparative study of the relative bioavailability of plant alkaloid harmine (native, in the form of a base) in comparison with its derivative harmine hydrochloride was carried out on chinchilla rabbit. Both substances was administered in capsules, containing an equimolar amount of harmine (50 mg, p.o.). Harmin hydrochloride was shown to have some pharmacokinetic advantages in comparison with native harmin due to a relatively rapid achievement of the maximal plasma concentration (Tmax) and a significantly higher maximum concentration of the active substance in the blood. At the same time, there was shown that the chemical modification of harmine does not significantly affect on such pharmacokinetics parameter as the area under the curve (AUC), which indicates the absence of a difference in the degree of absorption in the compared dosage forms.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>бета-карболиновые алкалоиды</kwd><kwd>гармин</kwd><kwd>гармина гидрохлорид</kwd><kwd>фармакокинетика</kwd><kwd>биодоступность</kwd></kwd-group><kwd-group xml:lang="en"><kwd>beta-carboline alkaloids</kwd><kwd>harmine</kwd><kwd>harmine hydrochloride</kwd><kwd>pharmacokinetics</kwd><kwd>bioavailability</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Zetler G, Back G, Iven H. Pharmacokinetics in the rat of the hallucinogenic alkaloids harmine and harmaline. Naunyn-Schmiedeberg's archives of pharmacology. 1974;285(3):273–292. DOI: 10.1007/bf00498996</mixed-citation><mixed-citation xml:lang="en">Zetler G, Back G, Iven H. Pharmacokinetics in the rat of the hallucinogenic alkaloids harmine and harmaline. Naunyn-Schmiedeberg's archives of pharmacology. 1974;285(3):273–292. DOI: 10.1007/bf00498996</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Guan Y, Louis ED, Zheng W. Toxicokinetics of tremorogenic natural products, harmane and harmine, in male Sprague-Dawley rats. Journal of toxicology and environmental health. Part A. 2001;64(8):645–660. DOI: 10.1080/152873901753246241</mixed-citation><mixed-citation xml:lang="en">Guan Y, Louis ED, Zheng W. Toxicokinetics of tremorogenic natural products, harmane and harmine, in male Sprague-Dawley rats. Journal of toxicology and environmental health. Part A. 2001;64(8):645–660. DOI: 10.1080/152873901753246241</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Tweedie DJ, Burke MD. Metabolism of the beta-carbolines, harmine and harmol, by liver microsomes from phenobarbitone- or 3-methylcholanthrenetreated mice. Identification and quantitation of two novel harmine metabolites. Drug metabolism and disposition: the biological fate of chemicals. 1987;15(1):74–81.</mixed-citation><mixed-citation xml:lang="en">Tweedie DJ, Burke MD. Metabolism of the beta-carbolines, harmine and harmol, by liver microsomes from phenobarbitone- or 3-methylcholanthrenetreated mice. Identification and quantitation of two novel harmine metabolites. Drug metabolism and disposition: the biological fate of chemicals. 1987;15(1):74–81.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Yu AM, Idle JR, Krausz KW, Kupfer A, Gonzalez FJ. Contribution of individual cytochrome P450 isozymes to the O-demethylation of the psychotropic beta-carboline alkaloids harmaline and harmine. The Journal of pharmacology and experimental therapeutics. 2003;305(1):315–322. DOI: 10.1124/jpet.102.047050</mixed-citation><mixed-citation xml:lang="en">Yu AM, Idle JR, Krausz KW, Kupfer A, Gonzalez FJ. Contribution of individual cytochrome P450 isozymes to the O-demethylation of the psychotropic beta-carboline alkaloids harmaline and harmine. The Journal of pharmacology and experimental therapeutics. 2003;305(1):315–322. DOI: 10.1124/jpet.102.047050</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
